Clinical Trials Directory

Trials / Terminated

TerminatedNCT01343680

Trial of Two Central Venous Catheter (CVC) Flushing Schemes in Pediatric Hematology and Oncology Patients

A Randomized Controlled Crossover Trial of Two Different Central Venous Catheter Flushing Schemes in Pediatric Hematology and Oncology Patients in Alberta, Canada

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
2 (actual)
Sponsor
Alberta Children's Hospital · Academic / Other
Sex
All
Age
17 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether flushing Central Venous Catheters (CVCs) with Normal saline once per week is not inferior to flushing with 10U/ml heparin 3 times per week, in preventing CVC occlusions.

Detailed description

Tunneled central venous catheters (CVCs) are now used routinely in pediatric hematology and oncology patients. Flushing with heparin solution is routinely recommended to prevent occlusion of long term CVCs, although the concentration of heparin used, and frequency of its use varies between centres. Once weekly Normal saline is also used successfully in some pediatric enters. There is little evidence to support one method over the other. The investigators have designed a randomised crossover trial to directly compare once weekly Normal saline flushing with 3 times per week 10U/ml heparin flushing, to determine whether Normal saline is not inferior to heparin.

Conditions

Interventions

TypeNameDescription
DRUGHeparin5ml 10 units/ml IV heparin 3 times per week
DRUGNormal saline10ml normal saline IV weekly

Timeline

Start date
2011-04-01
Primary completion
2012-05-01
Completion
2012-05-01
First posted
2011-04-28
Last updated
2012-05-30

Locations

2 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT01343680. Inclusion in this directory is not an endorsement.